NCT00438568View on ClinicalTrials.gov

SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)

PHASE2CompletedINTERVENTIONAL
Enrollment

173

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Mild Cognitive ImpairmentAlzheimer's Disease
Interventions
DRUG

Regular Insulin

administered intra-nasally twice a day for 16 weeks

DRUG

Placebo

administered intra-nasally twice a day for 16 weeks

Trial Locations (1)

98108

Veterans Administration Puget Sound Health Care System, Seattle

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of Washington

OTHER

NCT00438568 - SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days) | Biotech Hunter | Biotech Hunter